PULMICARE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.1% 7.0% 8.0% 8.0% 17.7%  
Credit score (0-100)  41 36 32 32 8  
Credit rating  BBB BBB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  199 150 83.7 37.1 2.9  
EBITDA  199 150 83.7 37.1 2.9  
EBIT  199 150 83.7 37.1 2.9  
Pre-tax profit (PTP)  242.0 144.5 90.5 38.6 -4.0  
Net earnings  188.4 112.7 69.7 30.0 -3.1  
Pre-tax profit without non-rec. items  242 144 90.5 38.6 -4.0  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  426 539 609 639 636  
Interest-bearing liabilities  245 233 48.7 41.6 0.0  
Balance sheet total (assets)  790 922 768 710 662  

Net Debt  -489 -641 -702 -654 -636  
 
See the entire balance sheet

Volume 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  199 150 83.7 37.1 2.9  
Gross profit growth  0.0% -24.5% -44.4% -55.7% -92.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  790 922 768 710 662  
Balance sheet change%  0.0% 16.8% -16.8% -7.6% -6.7%  
Added value  199.2 150.4 83.7 37.1 2.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  31.5% 17.6% 12.0% 6.2% 0.6%  
ROI %  37.0% 20.8% 14.2% 6.9% 0.6%  
ROE %  44.2% 23.3% 12.1% 4.8% -0.5%  

Solidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  54.0% 58.5% 79.3% 90.0% 96.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -245.5% -426.4% -838.1% -1,765.3% -22,064.4%  
Gearing %  57.4% 43.3% 8.0% 6.5% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  5.2% 2.5% 7.7% 16.5% 37.9%  

Liquidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  2.2 2.4 4.8 10.0 24.9  
Current Ratio  2.2 2.4 4.8 10.0 24.9  
Cash and cash equivalent  733.8 874.7 750.2 695.7 636.3  

Capital use efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  426.5 539.2 608.9 638.8 635.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0